Pelz, Robert K <br/><br/>
Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.  [electronic resource] 

 -  Intensive care medicine  Jun 2002 
 - 692-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0342-4642 
<br/><br/><label>Standard No.: </label>10.1007/s00134-002-1276-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>APACHE<br/>Anti-Bacterial Agents--therapeutic use<br/>Bacterial Infections--classification<br/>Endpoint Determination<br/>Enterococcus<br/>Female<br/>Hospital Mortality<br/>Humans<br/>Intensive Care Units--economics<br/>Length of Stay--economics<br/>Liver Transplantation--economics<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Treatment Outcome<br/>Vancomycin--therapeutic use<br/>Vancomycin Resistance